MultiplexDX™ is an international corporation established in 2015 consisting of two units: MultiplexDX Inc. located in Maryland U.S.A. and MultiplexDX s.r.o. located in Slovakia.
The primary objectives of the company are:
- development of the technologies and the products for molecular diagnostic markets superior to currently available products
- core facility service using proprietary Multiplex™ technology
- development of hi-tech 3D digital pathology services.